Antimicrobials · Cephalosporins
The facts most likely to be tested
Press 1–5 to rate · ↑↓ to navigate
Cefuroxime is a second-generation cephalosporin that provides expanded Gram-negative coverage compared to first-generation agents while maintaining efficacy against Gram-positive cocci.
The drug is a preferred oral agent for the treatment of community-acquired pneumonia (CAP) in patients with comorbidities due to its activity against Streptococcus pneumoniae and Haemophilus influenzae.
Cefuroxime is a standard treatment option for acute bacterial rhinosinusitis and acute otitis media in patients with penicillin allergies (non-anaphylactic).
Unlike first-generation cephalosporins, cefuroxime possesses increased stability against beta-lactamases produced by common respiratory pathogens.
Cefuroxime is frequently utilized for surgical prophylaxis in clean-contaminated procedures, particularly in orthopedic and cardiothoracic surgeries.
The drug lacks activity against atypical pathogens such as Mycoplasma pneumoniae and Legionella pneumophila, necessitating combination therapy if these are suspected in pneumonia.
Cefuroxime does not provide coverage against Pseudomonas aeruginosa or anaerobes like Bacteroides fragilis.
Vignette unlocked
A 54-year-old male with a history of COPD presents with a 4-day history of productive cough, fever, and pleuritic chest pain. Physical examination reveals dullness to percussion and bronchial breath sounds in the right lower lobe. A chest X-ray confirms a lobar consolidation. The patient has a history of a mild maculopapular rash when taking amoxicillin in the past. He is hemodynamically stable and is being discharged for outpatient management.
Which of the following is the most appropriate antibiotic for this patient?
Cefuroxime
The patient has CAP with comorbidities and a non-anaphylactic penicillin allergy, making a second-generation cephalosporin like cefuroxime an option; per IDSA, comorbid outpatient CAP also requires atypical coverage, so add a macrolide or doxycycline (or use a respiratory fluoroquinolone).
Full handout
High yield triage
Classification
Second-generation cephalosporin; beta-lactam antibiotic.
Indications
Community-acquired pneumonia, acute otitis media, sinusitis, and Lyme disease.
Mechanism of Action
Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs).
Side Effects
Diarrhea, nausea, and rash; anaphylaxis and C. difficile colitis.
Contraindications / Monitoring
History of severe hypersensitivity; monitor renal function (CrCl) for dosage adjustment.
Full handout
Mechanism of Action
Cefuroxime binds to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall. This binding inhibits the final transpeptidation step of peptidoglycan synthesis. The resulting cell wall defect leads to cell lysis and death. It maintains stability against many beta-lactamases compared to first-generation agents.
Unique Properties
Unlike most second-generation cephalosporins, cefuroxime possesses enhanced activity against Haemophilus influenzae and Moraxella catarrhalis. Despite some blood-brain barrier penetration, cefuroxime causes delayed CSF sterilization and treatment failures in bacterial meningitis and should not be used for CNS infections.
Indications
It is a preferred oral agent for community-acquired pneumonia and acute bacterial sinusitis. It is also indicated for acute otitis media in patients who have failed first-line therapy. Additionally, it is an effective alternative for early Lyme disease in patients who cannot tolerate doxycycline.
Pharmacokinetics
Cefuroxime axetil is an oral prodrug that is hydrolyzed to active cefuroxime in the intestinal mucosa. It is primarily excreted unchanged by the kidneys via glomerular filtration and tubular secretion. Dosage adjustments are mandatory in patients with significant renal impairment to prevent accumulation.
Side Effects & Adverse Events
Common adverse effects include gastrointestinal distress, specifically diarrhea and nausea. Patients may experience a maculopapular rash. Anaphylaxis is a rare but life-threatening hypersensitivity reaction. Clostridioides difficile-associated diarrhea is a serious risk following broad-spectrum antibiotic use.
Contraindications
Absolute contraindication is a history of severe anaphylactic reaction to any beta-lactam antibiotic. Use with extreme caution in patients with a history of penicillin allergy, as cross-reactivity may occur. Do not use in patients with known hypersensitivity to the cephalosporin class.
Monitoring
Monitor renal function (serum creatinine and calculated CrCl) periodically, especially in the elderly. Assess for signs of superinfection, such as persistent diarrhea or oral thrush. Evaluate for clinical improvement of the primary infection within 48-72 hours.
Clinical Pearls
Think of cefuroxime as the 'workhorse' for respiratory infections when H. influenzae is suspected. It is a classic board answer for Lyme disease in children or pregnant patients who have a contraindication to tetracyclines. Remember the cephalosporin cross-reactivity rule: avoid if the patient has a history of IgE-mediated penicillin reactions.